Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 2Phase 3 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

Exercise 419Blood Specimen Collection 318Standard of Care 299Surveys and Questionnaires 241Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 100Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Thymalfasin × Clear all
NCT06607926 2024-09-23

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Xuanwu Hospital, Beijing

Phase NA Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06598839 2024-09-19

Immuno-effect of Tα1 for Stage I NSCLC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡